嘧啶的研究:4-甲基-5-乙基-2,6-二甲氧基嘧啶的分子重排作用

(1)4-甲基5-乙基-2,6-二氯代嘧啶曾用磷醯氯和五氯化磷与其相应的2,6-二羟基嘧啶作用制取。(2)4-甲基-5-乙基-2,6-二氯代嘧啶与醇钠作用,极易转变成4-甲基-5-乙基-2,6-二烷氧基嘧啶。(3)4-甲基-5-乙基-2,6-二甲氧基嘧啶和2-氧代-3,4-二甲基-5-乙基-6-甲氧基嘧啶在高温时重排成其稳定构型的(或称内醯胺)的异构体:1,3,4-三甲基-5-乙基-2,6-二氧代嘧啶。另一方面,4-甲基-5-乙基-2,6-二甲氧基嘧啶用碘代甲烷处理并长久放置则仅仅发生部分重排作用,得到2-氧代-3,4-二甲基-5-乙基-6-甲氧基嘧啶。     

嘧啶的研究:4-甲基-2-6-二甲氧基嘧啶的分子重排作用

(1)4-甲基-2,6-二氯代嘧啶與鈉醇和醇的溶液作用,可以形成相應的2,6-二烴氧基嘧啶。 (2)4-甲基-2,6-二甲氧基嘧啶加熱至高温度即可轉變成其穩定結構的異構體1,3,4-三甲基-2,6-二羥基嘧啶。另一方面,在碘代甲烷催化劑的影響下,部份轉變成2-氧代-3,4-二甲基-6-甲氧基嘧啶;此化合物加熱卽可發生完全的轉變作用而形成其異構體1,3,4-三甲基-2,6-二羥基嘧啶。     

5-二乙氨甲基-6-甲基嘧啶-2,4-二酮的合成及抗炎活性

经由6-甲基嘧啶-2,4-二酮(6-甲基尿嘧啶)在无水乙醇中与甲醛和二乙胺反应,得到5-二乙氨甲基-6-甲基嘧啶-2,4-二酮;研究了影响反应收率的各种因素;利用质谱和核磁共振谱对产品进行了结构鉴定;同时利用小鼠耳肿胀试验测定了产物的抗炎活性.结果表明,所制备的5-二乙氨甲基-6-甲基嘧啶-2,4-二酮具有显著的抗炎活性.     

新型含嘧啶基团的弯曲型π-共轭化合物的合成

在Pd(0)催化下,5-溴-2-碘嘧啶分别与3,5-二(4,4,5,5-四甲基-1,3,2-二氧杂戊硼烷-2-基)苯甲醚和3,5-二(4,4,5,5-四甲基-1,3,2-二氧杂戊硼烷-2-基)苯十二烷基醚经Suzuki-Miyaura交叉偶联反应合成了两种新型的含有嘧啶基团的弯曲型π共轭体系化合物———3,5-二(5-溴-嘧啶基)苯甲醚和3,5-二(5-溴-嘧啶基)苯十二烷基醚(6);6在Ni(cod)2的催化下经聚合反应合成了其二聚体,其结构经1H NMR,13C NMR和EI-MS表征。     

2-[2-(4,6-二甲基)-嘧啶基]-4-苯基-1,2,4-噁二唑烷-3,5-二酮的合成

异氰酸苯醇和N-[2-(4,6-二甲基)-嘧啶基]-羟胺(5)反应生成1-[2-(4,6-二甲基)-嘧啶基]-1-羟基-3-苯基脲(6)。化合物(6)在三乙胺存在下和氯甲酸乙醇反应生成2-[2-(4,6-二甲基)-嘧啶基]-4-苯基-1,2,4-噁二唑烷-3,5-二酮(1)。     

2-[2-(4, 6-二甲基)-嘧啶基]-4-苯基-1, 2, 4-恶二唑烷-3, 5-二酮的合成

异氰酸苯酯和N-[2-(4, 6-二甲基)-嘧啶基]-羟胺(5)反应生成1-[2-(4, 6-二甲基)-嘧啶基]-1-羟基-3-苯基脲(6)。化合物(6)在三乙胺存在下和氯甲酸乙酯反应生成2-[2-(4, 6-二甲基)-嘧啶基]-4-苯基-1, 2, 4-恶二唑烷-3, 5-二酮(1)。     

双4,6-二甲基嘧啶-2-巯基衍生物的水相合成

2-巯基-4,6-二甲基嘧啶与碘(或卤代烷)在水溶液中反应合成了4种双4,6-二甲基嘧啶-2-巯基衍生物,其结构经1H NMR,IR,MS,元素分析和单晶X射线衍射表征.     

1,1-二氨基-2,2-二硝基乙烯的合成研究进展

1,1-二氨基-2,2-二硝基乙烯（FOX-7）是一种低感度高能量的新型含能材料.现有的1,1-二氨基-2,2-二硝基乙烯的合成包括以2-甲基咪唑、盐酸乙脒与乙二酸二乙酯、2-甲基-4,6-二羟基嘧啶为前体的三条合成路线.使用硫酸/硝酸体系硝化2-甲基-4,6-二羟基嘧啶可得到2-二硝基亚甲基-5,5-二硝基嘧啶-4,6-二酮,然后水解可得到FOX-7,正相硅胶薄层色谱可对该反应进行监测.使用曲拉通X-100/正己烷体系的反相微乳法可制备FOX-7球形纳米晶;FOX-7球形纳米晶具有良好的应用前景,对其合成工艺与路线进行探索和研究具有一定的意义.     

嘧啶的研究:氯对硫醇嘧啶的作用2-酮-4-氨基-5,6-二甲基-1,2-二氢-嘧啶的合成

1.甲醇鈉對於2-乙硫醇基-4,5-二甲基-6-氯代嘧啶在甲醇溶液中生成相應的乙硫醇基嘧啶甲醚。 2.氯對於2-乙硫醇基-4,5-二甲基嘧啶衍生物(I),在水溶液中的作用是特殊的,嘧啶中的不飽和現象不被氯化反應改變而硫醇基團被氧化,形成穩定相應嘧啶碸的衍生物(II),因此製備了2-乙磺醯基-4,5-二甲基-6-甲氧基嘧啶和2-乙磺醯基-4,5-二甲基-6-氯代嘧啶. 3.2-乙硫醇-4,5-二甲基-6-甲氧基嘧啶在甲醇中進行氯化反應,現象甚複雜,並且嘧啶碸的產量很低,2-乙硫醇-4,5-二甲基-6-甲氧基嘧啶在甲醇中被氯氧化,首先形成嘧啶碸,後者並不穩定,再與氯作用形成乙磺醯氯和2-氯代-4,5-二甲基-6-甲氧基嘧啶。 4.嘧啶碸與鹼作用,乙磺醯基被羥基取代,同時在嘧啶環6位上的乙氧基保留,因此2-乙磺醯基-6-甲氧基-4,5-二甲基嘧啶與鹼作用,形成2-酮-5,6-二甲基-4-甲氧基-1,2-二氫嘧啶。 5.酒精-氨的溶液作用在氯代乙磺醯基嘧啶得到氨基-乙磺醯基嘧啶,在氯代乙磺醯基嘧啶中,嘧啶環上2位的乙磺醯基仍保留,而6位土的氯被氨基取代。 6.本文敘述了合成4,5-二甲基-2-氧代-6-氨基嘧啶(或2-酮-4-氨基-5,6-二甲基-1,2-二氫化嘧啶)的新方法。     

Sinularia属珊瑚中嘧啶类化合物的分离与鉴定

分离和鉴定了采自中国南海硇州岛软珊瑚Sinularia Bassica样本中新的嘧啶类化合物。样本用工业酒精提取,提取物溶液经乙酸乙酯萃取后,萃取物经硅胶柱层析,以极性不断增大的溶剂体系(石油醚-乙酸乙酯、氯仿-甲醇)梯度洗脱,再经过HPLC分离,得到2,4(1H,3H)-嘧啶二酮、5-甲基-2,4(1H,3H)-嘧啶二酮、1,3-二甲基-2,4(1H,3H)-嘧啶二酮和5-甲氧基-1,3-二甲基-2,4(1H,3H)-嘧啶二酮4种新的嘧啶类化合物,其结构通过红外光谱、1HNMR和13C NMR等光谱数据分析确定。     

2-芳基-5-(4-硝基苯甲酰氨基)-1,3,4-噻二唑的合成

以芳甲酰肼和对硝基苯甲酰氯为主要原料, 合成出了10个酰氨基硫脲化合物5a～5j, 其中有6个(5d, 5f～5j)为新化合物. 在无需任何酸性催化剂条件下, 将制得的酰氨基硫脲在DMF中加热回流直接脱水关环合成出了9个2-芳基-5-(4-硝基苯甲酰氨基)-1,3,4-噻二唑化合物6a～6i, 其中7个(6b～6d, 6f～6i)为新化合物. 利用IR和1H NMR证明了化合物5存在两种异构体. 目标产物的结构通过IR, 1H NMR和元素分析进行了表征.     

Iron-molybdenum charge-transfer hybrids containing organometallic and inorganic fragments bridged by aryldiazenido ligands in a mu-eta(6):eta(1) coordination mode: syntheses, characterization, X-ray structures, electrochemistry, and theoretical investigation

Representative members of a new family of covalently bonded charge-transfer molecular hybrids, of general formula [(eta5-C5H5)Fe(mu,eta6:eta1-p-RC6H4NN)Mo(eta2-S2CNEt2)3] +PF6- (R: H, 5+PF6-; Me, 6+PF6-; MeO, 7+PF6-) and [(eta5-C5Me5)Fe(mu,eta6:eta1-C6H5NN)Mo(eta2-S2CNEt2)3]+PF6-, 8+PF6-, have been synthesized by reaction of the corresponding mixed-sandwich organometallic hydrazines [(eta5-C5H5)Fe(eta6-p-RC6H4NHNH2)]+PF6- (R: H, 1+PF6-; Me, 2+PF6-; MeO, 3+PF6-) and [(eta5-C5Me5)Fe(eta6-C6H5NHNH2)]+PF6-, 4+PF6-, with cis-dioxomolybdenum(VI) bis(diethyldithiocarbamato) complex, [MoO2(S2CNEt2)2], in the presence of sodium diethyldithiocarbamato trihydrate, NaSC(=S)NEt2.3H2O, in refluxing methanol. These iron-molybdenum complexes consist of organometallic and inorganic fragments linked each other through a pi-conjugated aryldiazenido bridge coordinated in eta6 and eta1 modes, respectively. These complexes were fully characterized by FT-IR, UV-visible, and 1H NMR spectroscopies and, in the case of complex 7+PF6-, by single-crystal X-ray diffraction analysis. Likewise, the electrochemical and solvatochromic properties were studied by cyclic voltammetry and UV-visible spectroscopy, respectively. The electronic spectra of these hybrids show an absorption band in the 462-489 and 447-470 nm regions in CH2Cl2 and DMSO, respectively, indicating the existence of a charge-transfer transition from the inorganic donor to the organometallic acceptor fragments through the aryldiazenido spacer. A rationalization of the properties of 5+PF6--8+PF6- is provided through DFT calculations on a simplified model of 7+PF6-. Besides the heterodinuclear complexes 5+PF6--8+PF6-, the mononuclear molybdenum diazenido derivatives, [(eta1-p-RC6H4NN)Mo(eta2-S2CNEt2)3] (R: H, 9; Me, 10; MeO, 11), resulting from the decoordination of the [(eta5-C5H5)Fe]+ moiety of complexes 5+PF6--7+PF6-, were also isolated. For comparative studies, the crystalline and molecular structure of complex 10.Et2O was also determined by X-ray diffraction analysis and its electronic structure computed.     

An eta(6)-dienyne transition-metal complex

The ruthenium complexes, [(eta5-C5R5)Ru(CH3CN)3]PF6 (1-Cp*, R = Me; 1-Cp, R = H), underwent reaction with both 1-(2-chloro-1-methylvinyl)-2-pentynyl-(Z)-cyclopentene (6-Z) and 1-(2-chloro-1-methylvinyl)-2-pentynyl-(E)-cyclopentene (6-E) to give (eta5-C5R5)Ru[eta6-(5-chloro-4-methyl-6-propylindan)]PF6 (7-Cp*, R = Me; 7-Cp, R = H). In a similar fashion, reaction of 1-Cp and 1-Cp* with 1-isopropenyl-2-pent-1-ynylcyclopentene (8) led to the formation of (eta5-C5R5)Ru(eta6-4-methyl-6-propylindan)]PF6 (9-Cp*, R = Me; 9-Cp, R = H). The reaction of 1-Cp* with 8 at -60 degrees C in CDCl3 solution led to observation of the eta6-dienyne complex, (eta5-C5Me5)Ru[eta6-(1-isopropenyl-2-pent-1-ynylcyclopentene)]PF6 (10), by 1H NMR spectroscopy. Complexes 7-Cp and 10 were characterized by X-ray crystallographic analysis.     

Novel and versatile reactions of trifluoroamine oxide: a new route to polyfluorinated ethers

A series of pyrimidine methyl and polyfluoroalkyl ethers were synthesized from the reactions of trifluoroamine oxide (1) with several 5-substituted uracils in the presence of tetrabutylammonium hydroxide and methanol, 2,2,2-trifluoroethanol (6), or 1H,1H-pentafluoropropanol (7). With 5-(trifluoromethyl)uracil (2), the new ethers formed were 5-fluoro-5-(trifluoromethyl)-6-methoxypyrimidine-2,4-dione (8), 5-fluoro-5-(trifluoromethyl)-6-(trifluoroethoxy)pyrimidine-2,4-dione (9), and 5-fluoro-5-(trifluoromethyl)-6-(1H,1H- pentafluoropropoxy)pyrimidine-2,4-dione (10). With 5-chlorouracil (3), the new ethers 5-chloro-5-fluoro-6-methoxypyrimidine-2,4-dione (11), 5-chloro-5-fluoro-6-(trifluoroethoxy)pyrimidine-2,4-dione (12), and 5-chloro-5-fluoro-6-(1H,1H-pentafluoropropoxy)pyrimidine-2,4-dione (13) were obtained. With 5-fluorouracil (4), the new ethers 5,5-difluoro-6-methoxypyrimidine-2,4-dione (14), 5,5-difluoro-6-(trifluoroethoxy)pyrimidine-2,4-dione (15) and 5,5 difluoro-6-(1H,1H-pentafluoropropoxy)pyrimidine-2,4-dione (16) were found. By reaction of 5-nitrouracil (5), the new ethers 5-nitro-5-fluoro-6 methoxypyrimidine-2,4-dione (17), 5-nitro-5-fluoro-6-(trifluoroethoxy)pyrimidine-2,4-dione (18), and 5-nitro-5-fluoro-6-(1H,1H-pentafluoropropoxy)pyrimidine-2,4-dione (19) were obtained. Each of the new compounds was characterized by using IR, 19F and 1H NMR, and mass spectroscopy, and elemental analysis. A single-crystal X-ray diffraction study of 8 was helpful in confirming compound structure.     

A quadruple helicene with a rubicene core: synthesis,structural analyses and properties

We report the synthesis of a quadruple helicene with a rubicene core R1 by a Scholl reaction.Among the 10 stereoisomers including 4 pairs of enantiomers and 2 meso isomers,only 2 pairs of enantiomers and 1 meso isomer have been isolated.The sample structures were unambiguously determined by X-ray crystallography to be(P,P)₆-(P,P)₅/(M,M)₆-(M,M)₅-R1-A,which has a propeller-shaped structure,and(M,M)₆-(P,P)₅/(P,P)₆-(M,M)₅-R1-B and(M,P)₆-(P,M)₅-R1-C,which have saddle-shaped structures.The chiral resolutions of R1 were carried out by chiral HPLC,revealing two pairs of chiral stereoisomers(P,P)₆-(P,P)₅/(P,P)₆-(M,M)₅,(M,M)₆-(P,P)₅/(M,M)₆-(M,M)₅ as well as a meso isomer(M,P)₆-(P,M)₅,which were further characterized by CD spectroscopy and time-dependent density functional theory(TD-DFT)calculations.Surprisingly,the UV-vis absorption and emission spectra of these resolved stereoisomers and unresolved R1 were almost identical.In addition,the chemical oxidation of R1 led to the formation of radical cations and dications at room temperature.     

Diastereoselective hydroxylation of 6-substituted piperidin-2-ones. An efficient synthesis of (2S,5R)-5-hydroxylysine and related alpha-amino acids

The synthesis of (2S,5R)-5-hydroxy-6-oxo-1,2-piperidinedicarboxylates (5) and related (3S,6R)-3-hydroxy-6-alkyl-2-oxo-1-piperidinecarboxylates has been developed. The approach is based on the asymmetric hydroxylation of enolates generated from the corresponding N-protected-6-substituted piperidin-2-ones. The utility of 5a as a precursor in the synthesis of (2S,5R)-5-hydroxylysine (1), an amino acid unique to collagen and collagen-like proteins, has also been demonstrated. (2S)-6-oxo-1,2-piperidinedicarboxylates (6) required for hydroxylation studies were prepared in 38-74% yield, starting from conveniently protected aspartic acid as inexpensive chiral adduct. Hydroxylation of 6 to 5 proceeds in high yield and excellent diastereoselectivity by treatment of their Li-enolate with (+)-camphorsulfonyloxaziridine at -78 degrees C. Ring opening of di-tert-butyl (2S,5R)-6-oxo-1,2-piperidinedicarboxylate ((5R)-5a) under reductive conditions afforded the corresponding 1,2-diol (17) in 91%, which was further transformed to (2S,5R)-5-hydroxylysine in four steps (84%). 17 is also a versatile intermediate in the preparation of tert-butyl (2S,5R)-2-[(tert-butoxycarbonyl)amino]-5-hydroxy-6-iodohexanoate (3) and tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-4-[(2R)-oxiranyl]butanoate (4), two amino acid derivatives used in the total synthesis of the bone collagen cross-link (+)-pyridinoline (2a).     

Homoleptic organometallic anions of Ti, Zr, Hf, and Nb

Reactions of C(6)H(5)Li and 4-CH(3)C(6)H(4)Li with halides of Ti, Ir, Hf, and Nb lead to the formation of homoleptic organometallic anions of these metals. Owing to their thermal instability and their sensitivity towards H(2) O and O(2) , these compounds are characterized by single-crystal structure determinations at low temperature, whereas other physical data could only be obtained occasionally. Three pentacoordinate complex anions [Ti(C(6)H(5))(5)](-), [Ti(4-CH(3)C(6)H(4))(5)](-), and [Zr(C(6)H(5))(5)](-) have square-pyramidal structures that display only slight deviations from the ideal geometry, in contrast to the already known structures of [Ti(CH(5))(5)](-). The hexacoordinate complex anions [Zr(C(6)H(5))(6)](2-), [Zr(4-CH(3)C(6)H(4))(6)](2-), [Nb(C(6)H(5))(6)](2-), and [Nb(4-CH(3)C(6)H(4))(6)](2-) all have trigonal-prismatic structures, in accord with the known hexamethyl complex dianions. In contrast, the hexacoordinate complex anion [Hf(C(6)H(5))(6)](2)(-) has an octahedral or close to octahedral structure, in contrast to the known trigonal-prismatic structures of [Ta(C(6)H(5))(6)](-) and [Ta(4-CH(3)C(6)H(4))(6) (-). A qualitative explanation for this structural variability is given.     

合成SGLT2抑制剂埃格列净的新方法

以D-(+)-葡萄糖酸内酯为原料,经三甲硅基保护羟基后与5-溴-2-氯-4′-乙氧基二苯甲烷偶联制得(2S,3R,4S,5S,6R)-2-［4-氯-3-(4-乙氧苄基)苯基］-6-(羟甲基)-2-甲氧基四氢-2H-吡喃-3,4,5-三醇（2）; 2经羟基保护、氧化和羟醛缩合等5步反应制得(3S,4S,5R,6S)-3,4,5-三(苄氧基)-6-［4-氯-3-(4-乙氧苄基)苯基］-2-(羟甲基)-6-甲氧基四氢-2H-吡喃-2-甲醛（7）; 7经还原、脱苄同时关环制得埃格列净(1S,2S,3S,4R,5S)-5-［4-氯-3-(4-乙氧苄基)苯基］-1-(羟甲基)-6,8-二氧杂二环［3.2.1］辛烷-2,3,4-三醇,其结构经¹H NMR和LC-MS表征。     

Synthesis of b-Cyclodextrin Bonded Metal Porphyrins

6-Deoxy- 6-iodo-b -cyclodextrin (1) reacted with 5-(p-aminophenyl)-10,15,20-triphenyl porphyrin(2), 5-(p-aminophenyl)-10,15,20-triphenyl nickel(II) porphyrin [NiⅡTPPNH2P] (3), 5-(p-aminophenyl)-10,15,20-triphenyl manganese(Ⅲ) porphyrin [MnⅢTPPNH2P] (4) and 5-(p-aminophenyl)-10,15,20-triphenyl carbonyl ruthenium porphyrin [RuⅡ(CO)TPPNH2P] (5) to generate the compounds 6-9, respectively. Those new compound 5-9 have been identified by 1H NMR, IR, MS and UV-visible spectra and elemental analysis.     

桥连双-(三氮杂环壬烷)化合物的合成

利用无水碳酸钾作缩合剂,在精制乙腈中使N,N'-二对甲苯磺酰基-1,4,7-三氮杂环壬烷3与双溴甲基化合物4a-4c缩合得到N-对甲苯磺酰基取代的桥连双-(三氮杂环壬烷)5a-5c,经浓硫酸脱去氮原子上的保护基团得到桥连双-(三氮杂环壬烷)6a-6c。化合物5a-5c和6a-6c均经元素分析、IR、^1HNMR、^1^3CNMR、MS等测试手段证实其结构和组成。